ENTA vs RF
Enanta Pharmaceuticals Inc (ENTA) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
RF does not have a complete income-statement cache yet.
ENTA currently screens at market cap $328.0M. RF currently screens at market cap $0.
Not investment advice. Open the ENTA and RF stock pages for the full models.
Not investment advice.